Proteomic analysis of radioiodine-refractory differentiated thyroid cancer

ABSTRACT: Radioiodine refractory differentiated thyroid cancer (RR-DTC) is the main factor affecting the overall survival rate of thyroid cancer clinically. In order to investigate its underlying molecular mechanism of pathogenesis with the hope to explore novel therapeutic targets for clinical treatment, we performed a comparative proteomic analysis in tumor tissue of patients with RR-DTC and papillary thyroid cancer.

ORGANISM(S): Homo Sapiens

SUBMITTER: Dong Duan  

PROVIDER: PXD037968 | iProX | Sat Nov 05 00:00:00 GMT 2022

REPOSITORIES: iProX